Hispanotels Inversiones SOCIMI SA is a Spain-based real estate investment trust primarily engaged in the acquisition, development, management, and leasing of a diversified portfolio of urban real estate properties. The company operates across four key business segments: Hotel Properties, Commercial Real Estate, Office Buildings, and Residential Assets. Its core product and service portfolio includes hotel property leasing and long-term asset management for hospitality assets leased to prominent hotel chains; commercial real estate leasing comprising prime ground-floor retail units and commercial spaces; office property leasing and corporate tenant facility administration across key metropolitan business districts; residential real estate rental and property management; and comprehensive asset management services, including strategic property acquisitions, value-add renovations, lease structuring, and asset optimization designed to generate stable, recurring rental income. Headquartered in Madrid, Spain, the entity has operational roots dating back to 1947 and assumed its current consolidated corporate SOCIMI structure in November 2017 following the merger of several historic family-held real estate companies, trading publicly on the BME Growth exchange under the ticker symbol YHSP. Hispanotels Inversiones SOCIMI maintains geographic operations across Spain, with the majority of its asset value concentrated in central Madrid alongside select holdings in Alcorcon, Jaen, and Girona. In recent corporate and operational developments, the company has executed strategic portfolio rationalization and asset repositioning strategies, highlighted by the divestment of non-core hotel assets including the Hotel Ciudad de Valladolid, targeted facility enhancements across existing holdings to maximize rental yields, ongoing shareholder remuneration programs via regular dividend distributions, and administrative governance updates through ordinary and extraordinary general shareholder meetings to streamline capital allocation and maintain regulatory alignment under the BME Growth market framework.